Invesco
RVMD icon

Invesco’s Revolution Medicines RVMD Stock Holding History

Invesco’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108M Buy
578,287
+185,443
+47% +$27.1M 0.01% 868
2026
Q1 		$38.2M Buy
392,844
+24,993
+7% +$2.52M ﹤0.01% 1181
2025
Q4 		$29.3M Buy
367,851
+166,909
+83% +$10.9M ﹤0.01% 1283
2025
Q3 		$9.38M Sell
200,942
-26,077
-11% -$1.02M ﹤0.01% 1858
2025
Q2 		$8.35M Buy
227,019
+36,760
+19% +$1.41M ﹤0.01% 1899
2025
Q1 		$6.73M Buy
190,259
+72,607
+62% +$2.95M ﹤0.01% 2015
2024
Q4 		$5.15M Sell
117,652
-29,594
-20% -$1.49M ﹤0.01% 2238
2024
Q3 		$6.68M Buy
147,246
+48,695
+49% +$2.12M ﹤0.01% 2052
2024
Q2 		$3.82M Buy
98,551
+4,120
+4% +$154K ﹤0.01% 2319
2024
Q1 		$3.04M Sell
94,431
-34,387
-27% -$1.02M ﹤0.01% 2481
2023
Q4 		$3.69M Sell
128,818
-76,584
-37% -$1.84M ﹤0.01% 2387
2023
Q3 		$5.69M Buy
205,402
+134,536
+190% +$3.99M ﹤0.01% 2136
2023
Q2 		$1.9M Buy
70,866
+10,348
+17% +$254K ﹤0.01% 2649
2023
Q1 		$1.31M Buy
60,518
+33,925
+128% +$835K ﹤0.01% 2801
2022
Q4 		$633K Sell
26,593
-329
-1% -$7K ﹤0.01% 3166
2022
Q3 		$530K Buy
26,922
+3,837
+17% +$84.3K ﹤0.01% 3224
2022
Q2 		$450K Buy
23,085
+146
+0.6% +$2.84K ﹤0.01% 3377
2022
Q1 		$586K Buy
22,939
+206
+0.9% +$4.48K ﹤0.01% 3309
2021
Q4 		$573K Buy
22,733
+2,984
+15% +$84.1K ﹤0.01% 3332
2021
Q3 		$543K Sell
19,749
-3,873
-16% -$113K ﹤0.01% 3394
2021
Q2 		$750K Buy
23,622
+14,568
+161% +$508K ﹤0.01% 3252
2021
Q1 		$415K Sell
9,054
-8,099
-47% -$363K ﹤0.01% 3418
2020
Q4 		$679K Buy
+17,153
New +$678K ﹤0.01% 3098
2020
Q3 		– Sell
-16,485
Closed -$521K – 3681
2020
Q2 		$521K Buy
+16,485
New +$518K ﹤0.01% 3110

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Invesco's RVMD Position: Q2 2026 in Review

Invesco increased its Revolution Medicines (RVMD) stake by 47% in Q2 2026, buying an estimated $27.1M and bringing the position to 578,287 shares worth $108M. The position accounts for 0.01% of the portfolio, ranked #868.

Invesco first reported a position in RVMD in Q2 2020 and has held it in 24 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Invesco held 578,287 shares of Revolution Medicines worth $108M as of Q2 2026.
  • Invesco bought 185,443 Revolution Medicines shares in Q2 2026, an estimated $27.1M.
  • Revolution Medicines made up 0.01% of Invesco's portfolio in Q2 2026, its #868 holding.
  • Invesco first reported a position in Revolution Medicines in Q2 2020 and has held it in 24 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.